期刊文献+

他汀类药物与运动关系的研究进展

Advances in the relationship between statins drugs and physical activities
下载PDF
导出
摘要 他汀类药物可能产生肌肉相关性不良反应,本文回顾他汀类药物与运动之间的关系。他汀类药物的应用对服药者的心肺适能、运动表现和运动耐力无明显影响,但对肌肉力量可能产生不利影响仍未达成共识。运动训练时使用他汀类药物虽有不良事件发生,但能够更有效地降低心血管疾病的风险。 Statins drugs may induce muscle-associated adverse reactions.The paper reviewed the relationship between statins and physical activities.The medication of statins has no obvious effects on cardiorespiratory function,athletic performance and exercise tolerance.However,there is no agreement so far as to its adverse effects on muscle strength.In spite of the fact that the application of statins during physical exercise may induce adverse events,it could effectively reduce the risk of cardiovascular disease.
出处 《药学服务与研究》 CAS 2018年第1期38-41,共4页 Pharmaceutical Care and Research
基金 国家自然科学基金(81470407)
关键词 他汀类 运动 肌肉力量 他汀相关肌肉症状 综述 statins physical activity muscle strength statin-associated muscle symptoms review
  • 相关文献

二级参考文献23

  • 1LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J]. New England Journal of Medicine, 2005, 352(14): 1425-1435. 被引量:1
  • 2KalenA, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues [J]. Lipids, 1989, 24(7): 579-584. 被引量:1
  • 3Singh RB, Neki NS, Kartikey K, et al, Effect of coenzyme Q10 on risk of Atherosclerosis in patients with recent myocardial infarction [J]. Mol Cell Biochem, 2003, 246(1-2): 75-82. 被引量:1
  • 4Mabuchi H, Nohara A, Kobayashi J, et al. Effects of CoQ10 supple- mentation on plasma lipoprotein lipid, CoQl0 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvas- tatin: A randomized double-blind study [J]. Atherosclerosis, 2007, 195(2): e182-189. 被引量:1
  • 5Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and me- ta-analysis of randomized controlled trials [J]. The American Joor- nal of Medicine, 2004, 116(10): 682-692. 被引量:1
  • 6Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events [J]. New Eng- land Journal of Medicine, 2007, 357(13): 1301-1310. 被引量:1
  • 7Grover SA, Kaouache M, Joseph L, et al. Evaluating the incremen- tal benefits of raising high-density lipoprotein cholesterol levels dur- ing lipid therapy after adjustment for the reductions in other blood lipid levels [J]. Archives of Internal Medicine, 2009, 169(19): 1775-1180. 被引量:1
  • 8Singh IM, Shishehbor MH, Ansell BJ. High-density lipoprotein as a therapeutic target: A systematic review [J]. JAMA, 2007, 298(7): 786-798. 被引量:1
  • 9Barter P J, Brandmp-Wognsen G, Palmer MK, et al. Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: anal- ysis of the VOYAGER Database [J]. Journal of Lipid Research, 2010, 51(6): 1546-1553. 被引量:1
  • 10Ichihara K, Satoh K. Disparity between angiographie regression and clinical event rates with hydrophobie statins [J]. Lancet, 2002, 359 (9324): 2195-2198. 被引量:1

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部